
Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes

Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
Founded: December 2018
Headquarters: New York, NY
Core offering: Single-cell multiomic immune mapping + ML platform (AMICA) for therapeutic discovery
Total funding: USD 295,000,000
| Company |
|---|
Immune system mapping to improve discovery and development of immunology and oncology therapeutics.
2018
Biotechnology Research
USD 20,000,000
USD 60,000,000
Raised to expand annotated multi-omic immune cell atlas; reported total after round > USD 80M
USD 215,000,000
Brought reported total funding to USD 295M
“Includes strategic and institutional investors such as Schusterman Family Investments, Catalio Capital Management, Viola/TLV, Piedmont Capital Investments, and Alexandria Venture Investments.”
About Immunai:
Immunai is an engineering-first platform company aiming to improve therapeutic decision-making throughout the drug discovery and development process. We are mapping the immune system at unprecedented scale and granularity and applying machine learning to this massive clinico-immune database, in order to generate novel insights into disease pathology for our partners - pharma companies and research institutes. We provide a comprehensive, end-to-end solution - from data generation and curation to therapeutics development, that continuously supports and validates the capabilities of our platform.
As drug development is becoming increasingly inefficient, our ultimate goal is to help bring breakthrough medicines to patients as quickly and successfully as possible.
Immunai is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
About the role:
We seek an exceptionally motivated Senior Systems Immunologist to join our team of talented researchers in a highly collaborative startup environment at the intersection of immunology, AI, and new genomic technologies. This position offers an opportunity to work directly with one of our big pharma partners on a diverse set of projects related to cancer immunology.
Location: New York, NY (Hybrid position, must be based in New York City)
Reporting to: Systems Immunology Team Lead, Collaborations
What will you do?
Required qualifications:
Desired personal traits:
Compensation: This position offers a base salary typically between $130,000 and $150,000. There is an opportunity to consider higher compensation above this range based on business need, candidate experience, and or skills.
*Please note that when you apply for a position at Immunai, your application will be processed via our recruitment platform Comeet. You can read more about how we process personal data here: https://www.immunai.com/privacy-policy/